Methods of treating patients having TLR3-positive cancer
US8715667B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2012 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Aug 15, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57492
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to antibodies, antibody fragments, and derivatives thereof that specifically bind to TLR3 cell receptors present on the surface of cells. The invention also relates to hybridomas producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same; methods of using the antibodies to detect TLR3 levels on the surface of cells, and the use of such antibodies and compositions for diagnostic or therapeutic purposes in subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.